Sutro Biopharma, Inc. STRO
8.72 USD +0.22 (+2.59%)
Regular-session close
8.72 0.00 0.00%
After hours · Nov 19, 4:26 PM ET
8.48 Day range 8.98
7.15 52-week range 43.85
- YTD
- -24.63%
- 1 year
- -4.18%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 102.48M | 62.04M | 153.73M | 67.77M | 61.88M | |
| 102.48M | 62.04M | 153.73M | 67.77M | 61.88M | |
| -158.37M | -238.45M | -89.28M | -128.94M | -98.52M | |
| -191.09M | -227.46M | -106.79M | -119.20M | -105.54M | |
| -22.49 | -29.40 | -17.80 | -23.50 | -22.90 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 58.99M | 191.16M | 70.14M | 48.13M | 31.29M | |
| 173.83M | 387.21M | 470.74M | 406.94M | 341.41M | |
| 306.28M | 342.61M | 321.09M | 189.90M | 88.84M | |
| 15.67M | 23.15M | 33.63M | 50.43M | 57.37M | |
| -132.45M | 44.60M | 149.65M | 217.05M | 252.56M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -177.23M | -191.54M | -111.62M | 3.55M | -81.68M | |
| 45.01M | 218.51M | -3.92M | -35.02M | -97.31M | |
| 44.00K | 94.05M | 137.55M | 48.31M | 3.26M | |
| -1.70M | -3.10M | -4.32M | -7.86M | -15.32M | |
| -132.17M | 121.02M | 22.01M | 16.84M | -175.74M |
